Oramed Pharmaceuticals Inc. (ORMP) NASDAQ
3.84
-0.06(-1.54%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.84
-0.06(-1.54%)
Currency In USD
| Market Cap | 118M |
| Enterprise Value | 72.88M |
| P/E Ratio | 2.11 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 77.66 |
| Price/Book Ratio | 0.8 |
| Enterprise/Revenue | 55.1 |
| Enterprise/EBITDA | -7.3 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 37.66 |
| Operating Margin | -7.54 |
| Return On Assets | 0.77 |
| Return On Equity | 0.43 |
| Revenue | 2M |
| Revenue/Share | 0.05 |
| Gross Profit | 13,000 |
| EBITDA | -15.09M |
| Net Income | 75.32M |
| Diluted EPS | 1.5 |
| Total Cash | 51.36M |
| Total Cash/Share | 1.24 |
| Total Debt | 825,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 6.98 |
| Book Value Per Share | 2.07 |
| 52-Week Change | 66.23 |
| 52-Week High | 3.96 |
| 52-Week Low | 1.98 |
| Moving Average 50 Days | 3.47 |
| Moving Average 200 Days | 2.8 |
| Average Volume | 142,596 |
| Shares Outstanding | 40.45M |
| % Held by Institutions | 26.48 |
| Trailing Annual Dividend Rate | 0.25 |
| Trailing Annual Dividend Yield | 6.51 |
| Payout Ratio | 0.14 |
| Last Split Factor | 1:12 |
| Last Split Date | January 23, 2013 |